Physician profile
Allison Wyll
NPI 1063408268
$5,972.29
in general payments reported to CMS, 2019-2025
19 companies · $550 in 2025
The $550 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $2,388 · 2021: $520 · 2022: $615 · 2023: $481 · 2024: $893 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,924.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $2,905.22 | 2020-2025 | |
| Acclarent, INC | $976.00 | 2019-2023 | Trudi Nav Cable, Relieva Spinplus |
| Integra Lifesciences Corporation | $552.53 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Optinose US, INC. | $311.81 | 2019-2025 | |
| Stryker Corporation | $250.66 | 2019-2025 | Clarifix |
| Medtronic, INC. | $187.99 | 2024-2025 | Propel |
| Chitogel Limited | $133.11 | 2023 | Chitogel Endoscopic Sinus Surgery Kit |
| Genzyme Corporation | $120.18 | 2024-2025 | |
| Olympus America INC. | $119.68 | 2019-2024 | |
| Alk-Abello, INC | $100.04 | 2019-2021 | |
| Intersect Ent, INC. | $78.47 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $77.38 | 2022-2024 | Dupixent |
| Glaxosmithkline, LLC. | $69.14 | 2021-2022 | |
| Davol INC. | $23.88 | 2020 | |
| Smith+Nephew, INC. | $18.44 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $17.71 | 2024 | Ryaltris |
| Neurent Medical Limited | $16.39 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.66 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Wyll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.